Preparing stock dashboard...

Tanvex BioPharma, Inc.

6541.TW - Taiwan - Healthcare - Biotechnology

Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.

Data updated June 17, 2026

Price
$40.45

Financial Snapshot

Metric Value ('000,000)
Report Changes

What changed?

Latest period compared with the previous period and the matching prior-year period.

Loading financial changes...

Stock Analysis

Scores this stock using the same metrics model as the compare page.

Metric Value Score
Price & Momentum

Technical Analysis

Calculated locally from stored daily price and volume history.

Loading technical analysis...

Price Chart

Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.